Skip NavigationSkip to Content

Identification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxis

  1. Author:
    Le, Y. Y.
    Ye, R. D.
    Gong, W. H.
    Li, J. X.
    Iribarren, P.
    Wang, J. M.
  2. Author Address

    NCI Frederick, Mol Immunoregulat Lab, Ctr Canc Res, Ft Detrick, MD 21702 USA. Chinese Acad Sci, Inst Nutr Sci, Shanghai, Peoples R China. Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL USA. NCI Frederick, Basic Res Program, Ctr Canc Res, Ft Detrick, MD 21702 USA Wang, JM, NCI Frederick, Mol Immunoregulat Lab, Ctr Canc Res, Bldg 560,Rm 31-40, Ft Detrick, MD 21702 USA
    1. Year: 2005
    2. Date: FEB
  1. Journal: Febs Journal
    1. 272
    2. 3
    3. Pages: 769-778
  2. Type of Article: Article
  1. Abstract:

    Formyl peptide receptor-like 1 (FPRL1) is a seven transmembrane domain, G protein-coupled receptor that interacts with a variety of exogenous and host-derived agonists. In order to identify domains crucial for ligand recognition by FPRL1, we used chimeric receptors with segments in FPRL1 replaced by corresponding amino acid sequences derived from the prototype formyl peptide receptor FPR. The chimeric receptors were stably transfected into human embryonic kidney epithelial cells and the capacity of the cells to migrate in response to formyl peptide receptor agonists was evaluated. Our results showed that multiple domains in FPRL1 are involved in the receptor response to chemotactic agonists with the sixth transmembrane domain and the third extracellular loop playing a prominent role. Interestingly, the N-terminus and a segment between the fourth transmembrane domain and the third intracellular loop of FPRL1 are important for receptor interaction with a 42 amino acid amyloid beta peptide (Abeta(42)), an Alzheimer's disease-associated FPRL1 agonist, but not with MMK-1, a synthetic FPRL1 agonist, suggesting that diverse agonists may use different domains in FPRL1. Considering the potential importance of FPRL1 in inflammation and neurodegenerative diseases, the identification of functional domains in this receptor will provide valuable information for the design of specific receptor antagonists

    See More

External Sources

  1. DOI: 10.1111/j.1742-4658.2004.04514.x
  2. WOS: 000227359400013

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel